Proceedings: Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinoma.
D000135:Acid Phosphatase / Q000097:blood; D000230:Adenocarcinoma / Q000188:drug therapy* / Q000201:enzymology / Q000532:radiotherapy / Q000601:surgery; D000814:Aniline Compounds / Q000627:therapeutic use; D001859:Bone Neoplasms; D003520:Cyclophosphamide / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D007016:Hypophysectomy; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D008926:Plicamycin / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000532:radiotherapy / Q000601:surgery
D000814:Aniline Compounds; D008466:Mechlorethamine; D003520:Cyclophosphamide; D000135:Acid Phosphatase; D008926:Plicamycin; D005472:Fluorouracil